Atom360’s Post

This is the economic burden Atom360 is aiming to solve with it's AI based scalable oral cancer screening solution in India 👉 https://lnkd.in/gQ9ymy4U Cancer imposes a significant financial burden on nations worldwide, yet early detection can dramatically reduce treatment costs and improve survival rates. However, many regions lack the necessary resources for widespread screening. Atom360 aims to address this issue with its innovative AI-driven app, Berry.care. This app provides affordable and scalable cancer screening solutions, enabling early-stage identification of cancer, which makes treatment more effective and less expensive. #AIstartup #AIforGood

Understanding the costs associated with cancer is vital in order that resources are used for maximum effect. And investing in prevention and early intervention is critical if we are going to reduce the emotional and physical impact of cancer on individuals, families, friends and those that care for people with cancer. Calculating the health care and wider costs of cancer - as well as assessing the cost-effectiveness of prevention, early intervention and treatment - is a fundamental challenge faced by decision makers across the health and social care system. The costs of cancer can be felt at an individual level: work by Macmillan has shown that most (83%) cancer patients incur an average cost of £570 per month as a result of their illness. It can also be felt in the national economy: Oxford University estimate the cost of cancer to the economy is £7.6 billion a year due to premature deaths and time taken off work. Costs and the health system The Independent Cancer Taskforce Report (ICTR) set out the need for there to be clearer accountability of spend on cancer and emphasised the need for action in prevention and early diagnosis to reduce the longer term burden on the health system. It says: “The National Audit Office has estimated cancer services cost the NHS approximately £6.7bn per annum in 2012/13. The Five Year Forward View projections indicate that this will grow by about 9% a year, implying a total of £13bn by 2020/21.” Recommendation 95 in the strategy specifically asks that: “NHS England and Public Health England should work with Monitor and other bodies to consider how to develop better health economic evaluation of new service models and interventions.” We have a dedicated health economics team that commissions work to assess the economic impact of prevention and early intervention, and an example of this is recent work on bowel cancer in direct response to Taskforce Recommendation 95. This work has summarised the available cost-effectiveness evidence. Cost-effectiveness is a key concept in health economics and is concerned with the value we get from the money spent – where value is often expressed in terms of improving both survival and quality of life. For instance if we invested resources in the best possible way in bowel cancer then we would see improvements in survival, and also improvements in the quality of life of individuals who are staged earlier and therefore do not suffer the more unpleasant effects of treatment that could potentially be avoided. This is why a ‘return on investment’ (RoI) type approach has been followed in this work: how do we make sure that resources are invested in such a way that we achieve health gains at the same time as avoiding health care and other system costs further down the line.

𝗣𝗮𝗻𝗰𝗿𝗲𝗮𝘁𝗶𝗰 𝗖𝗮𝗻𝗰𝗲𝗿 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗠𝗼𝗻𝘁𝗵 💜 November is #PancreaticCancer Awareness Month, a time to shine a light on one of the deadliest forms of cancer and to drive support for research, early detection, and treatment. Pancreatic cancer is often diagnosed late, making awareness and education essential to improve outcomes. 𝗪𝗵𝗮𝘁 𝘆𝗼𝘂 𝘀𝗵𝗼𝘂𝗹𝗱 𝗸𝗻𝗼𝘄: 💜 Pancreatic cancer is the 3rd leading cause of cancer-related deaths 💜 Approximately 60,000 people are diagnosed each year in the US alone 💜 Only about 10% of patients survive five years post-diagnosis due to late detection 💜 Early symptoms can include jaundice, abdominal or back pain, unintended weight loss, and digestive issues 𝗛𝗲𝗿𝗲 𝗮𝗿𝗲 𝟱 𝘀𝘁𝗮𝗿𝘁-𝘂𝗽𝘀 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗻𝗴 𝗶𝗻 𝘁𝗵𝗶𝘀 𝘀𝗽𝗮𝗰𝗲: 💜 Reccan AB – Developers of an easy-to-use #bloodtest for early detection and improve prognosis of #pancreaticcancer 💜 EndoSound – Developers of #EUS technology to detect pancreatic cancer, #coloncancer, #IBD and other #gastrointestinal disorders 💜 Galen Health – Developers of #OncoSight, #AI-powered platform for early detection of pancreatic cancer 💜 Limaca Medical Ltd Medical – Developers of #PrecisionGI, EUS guided motorized #biopsy technology for detection of pancreatic and #GI Cancers 💜 Amplified Sciences, Inc. – Developers of an assay for early detection of pancreatic cancers, as well as #kidney disease Let’s use November to increase awareness, support those affected, and push for progress in pancreatic cancer research. #PancreaticCancerAwareness #cancerawareness #PancreaticCancer #endoscopy #oncology #medtech #medicaldevices #executivesearch #recruitment #pancreas #startups #healthtech #dx #innovation 

🚨 𝙁𝙞𝙧𝙨𝙩 𝙥𝙖𝙩𝙞𝙚𝙣𝙩 𝙙𝙚𝙘𝙡𝙖𝙧𝙚𝙙 ‘𝙘𝙖𝙣𝙘𝙚𝙧 #𝙛𝙧𝙚𝙚’ 𝙪𝙨𝙞𝙣𝙜 𝙞𝙣𝙙𝙞𝙜𝙚𝙣𝙤𝙪𝙨 𝘾𝘼𝙍-𝙏 𝙘𝙚𝙡𝙡 𝙩𝙝𝙚𝙧𝙖𝙥𝙮 𝙞𝙣 𝙄𝙣𝙙𝙞𝙖, 𝙗𝙮 𝙥𝙖𝙮𝙞𝙣𝙜 𝙟𝙪𝙨𝙩 42 𝙡𝙖𝙠𝙝 𝙞𝙣𝙨𝙩𝙚𝙖𝙙 𝙤𝙛 4 𝙘𝙧𝙤𝙧𝙚 𝙖𝙗𝙧𝙤𝙖𝙙........😱 . . . . . . Cancer has been a major public health concern and is a growing burden in India. The latest estimates suggest that new cancer diagnoses in the country reached nearly 1.6 million in 2023. 🟣 𝙒𝙝𝙖𝙩 𝙞𝙨 𝘾𝘼𝙍 𝙏-𝙘𝙚𝙡𝙡 𝙏𝙝𝙚𝙧𝙖𝙥𝙮.. ⁉️ 🔰 CAR T-cell therapies are a major breakthrough in #cancer treatment. 🔰Unlike #chemotherapy or #immunotherapy which involve taking drugs, CAR T-cell therapies use a patient's own cells. They are modified in the laboratory to activate T-cells and target #tumor cells. 🔰 CAR T-cell therapy has been approved for leukaemias (cancers arising from the cells that produce white blood cells) and #lymphomas (arising from the lymphatic system). 🟣 𝙋𝙧𝙤𝙘𝙚𝙙𝙪𝙧𝙚: 🔰 T cells are taken from a patient’s blood and then the gene for a #special receptor that binds to a certain protein on the patient’s cancer cells is added to the T cells in the laboratory. 🔰 The special #receptor is called a chimeric antigen receptor (CAR). Large numbers of the CAR T #cells are grown in the laboratory and given to the patient by infusion. 𝙏𝙝𝙞𝙨 𝙞𝙨 𝙜𝙧𝙚𝙖𝙩 𝙣𝙚𝙬𝙨. 𝙂𝙤𝙫𝙚𝙧𝙣𝙢𝙚𝙣𝙩 𝙣𝙚𝙚𝙙 𝙩𝙤 𝙞𝙣𝙫𝙚𝙨𝙩 𝙢𝙤𝙧𝙚 𝙞𝙣 𝙨𝙘𝙞𝙚𝙣𝙩𝙞𝙛𝙞𝙘 𝙝𝙚𝙖𝙡𝙩𝙝𝙘𝙖𝙧𝙚 𝙧𝙚𝙨𝙚𝙖𝙧𝙘𝙝. 𝙏𝙝𝙞𝙨 𝙬𝙞𝙡𝙡 𝙝𝙚𝙡𝙥 𝙗𝙪𝙞𝙡𝙩 𝙄𝙣𝙙𝙞𝙖 𝙖𝙨 𝙖 𝙙𝙚𝙨𝙩𝙞𝙣𝙖𝙩𝙞𝙤𝙣 𝙛𝙤𝙧 𝙖𝙛𝙛𝙤𝙧𝙙𝙖𝙗𝙡𝙚 𝙖𝙣𝙙 𝙗𝙚𝙨𝙩 𝙙𝙚𝙨𝙩𝙞𝙣𝙖𝙩𝙞𝙤𝙣 𝙛𝙤𝙧 𝙩𝙧𝙚𝙖𝙩𝙢𝙚𝙣𝙩. 𝙍𝙚𝙙𝙪𝙘𝙞𝙣𝙜 𝙩𝙝𝙚 𝙘𝙤𝙨𝙩 𝙤𝙛 𝙩𝙧𝙚𝙖𝙩𝙢𝙚𝙣𝙩 𝙗𝙮 90% 𝙞𝙨 𝙜𝙤𝙞𝙣𝙜 𝙩𝙤 𝙝𝙚𝙡𝙥 𝙢𝙖𝙣𝙮 𝙛𝙖𝙢𝙞𝙡𝙞𝙚𝙨. . . . . . 🌟 𝘈 𝘳𝘦𝘮𝘢𝘳𝘬𝘢𝘣𝘭𝘦 𝘧𝘦𝘢𝘵 𝘧𝘰𝘳 𝘵𝘩𝘦 𝘐𝘯𝘥𝘪𝘢𝘯 𝘮𝘦𝘥𝘪𝘤𝘢𝘭 𝘧𝘪𝘦𝘭𝘥 🌟 #cancer #treatment #cancerresearch #cancercare #cancerprevention #cancersurvivor #cancerwarrior #government #facility #healthcare #research #marketupdates #linkedin #linkedinforcreators #linkedinpost

Google is Using AI Models to Tackle High-Mortality Diseases like Tuberculosis, Breast Cancer and Many More in India #2YoDoINDIA #AI #ApolloRadiologyInternational #ArtificialIntelligence #BreastCancer #GOOGLE #GOOGLEAI #Healthcare #HighMortalityDiseases #LungCancer #Tuberculosis

Check Yourself, Protect Yourself! Dr Rahul Jena, Consultant, Uro-oncology at Bagchi Sri Shankara Cancer Centre and Research Institute, explains the importance of early detection of testicular cancer, a condition that commonly affects men between the ages of 15 and 40 years.  How to catch it early? Dr Rahul Jena highlights the importance of monthly testicular self-examinations for men. This simple yet effective practice involves carefully feeling both testicles to check for any unusual changes, such as areas of hardness, lumps, or swelling. He explains that while the majority of such changes may not necessarily indicate cancer, any irregularities should never be ignored. Consulting a urologist can lead to early detection and timely intervention, and can significantly improve the chances of successful treatment.    Early detection is the key to better outcomes, and self-awareness plays a critical role in maintaining men’s health. Taking a few minutes each month for this examination can make a life-saving difference. . . . . #bagchisrishankaracancercentreandresearchinstitute #cancercare #noshavenovember #movember #testicularcancer #menshealth #cancerawareness #selfexamination #earlydetection #urooncology #bagchisrishankara #prevention #healthtips #doctor #bhubaneswar #odisha #india #vlog #viral #trending #foryou #foryoupage . . . . [ Bagchi Sri Shankara Cancer Centre And Research Institute | Cancer Care | No Shave November | Movember | Testicular Cancer | Men's Health | Cancer Awareness | Self Examination | Early Detection | Uro Oncology | Bagchi Sri Shankara | Prevention | Health Tips | Doctor | Bhubaneswar | Odisha | India | Vlog | Viral | Trending | For You | For You Page ]

Oral cancer poses a significant challenge today, particularly in rural areas where regular screenings are rare, allowing the disease to progress undetected. Oraicle is dedicated to changing this through innovative technology. Our mission is to develop a solution that is not only technologically advanced but also user-friendly and accessible to everyone. We aim to break down geographical barriers, bringing crucial healthcare to the most remote corners of India. Our goal is to empower each individual with the power of early detection, taking control of their health. As we continue our journey, we're focused on more than just technology or medical breakthroughs; timely intervention is key. Early detection significantly increases the chances of successful treatment and saving lives. It's our main tool in the fight against oral cancer. Our vision is to make this powerful tool widely available, moving towards a future where oral cancer is not a daunting threat but a preventable and manageable condition. Join us in this mission to change the narrative and create a healthier future.

A Proud Milestone for India in Cancer Treatment! 🇮🇳 Today, I am incredibly proud to share the news I stumbled upon regarding NexCAR19, India’s first indigenous CAR-T cell therapy, developed through the collaboration of IIT Bombay, Tata Memorial Centre, and ImmunoACT. This revolutionary treatment is designed to target blood cancers like B-cell lymphoma, providing hope to patients who have not responded to conventional therapies like chemotherapy. This breakthrough reflects not only India’s scientific prowess but also our ability to innovate solutions that are both cutting-edge and affordable. While similar treatments abroad can cost up to $400,000, NexCAR19 is available at ₹30-40 lakhs, a fraction of the international price. Still, for many families in India, this remains out of reach. Now is the time for the Indian government to step in and provide subsidies for such life-saving treatments. By doing so, we can make this treatment accessible to a wider population and reduce the financial burden on families battling cancer. Subsidizing this indigenous treatment will not only improve accessibility but will also place India at the forefront of affordable and effective cancer care on the global stage. Let’s continue to celebrate our strides in medical innovation, while also pushing for policies that ensure healthcare is a right, not a privilege. 👏 #ProudIndian #CancerTreatment #NexCAR19 #MedicalInnovation #AffordableHealthcare #SubsidiesForAll

Understanding the costs associated with cancer is vital in order that resources are used for maximum effect. And investing in prevention and early intervention is critical if we are going to reduce the emotional and physical impact of cancer on individuals, families, friends and those that care for people with cancer. Calculating the health care and wider costs of cancer - as well as assessing the cost-effectiveness of prevention, early intervention and treatment - is a fundamental challenge faced by decision makers across the health and social care system. The costs of cancer can be felt at an individual level: work by Macmillan has shown that most (83%) cancer patients incur an average cost of £570 per month as a result of their illness. It can also be felt in the national economy: Oxford University estimate the cost of cancer to the economy is £7.6 billion a year due to premature deaths and time taken off work. Costs and the health system The Independent Cancer Taskforce Report (ICTR) set out the need for there to be clearer accountability of spend on cancer and emphasised the need for action in prevention and early diagnosis to reduce the longer term burden on the health system. It says: “The National Audit Office has estimated cancer services cost the NHS approximately £6.7bn per annum in 2012/13. The Five Year Forward View projections indicate that this will grow by about 9% a year, implying a total of £13bn by 2020/21.” Recommendation 95 in the strategy specifically asks that: “NHS England and Public Health England should work with Monitor and other bodies to consider how to develop better health economic evaluation of new service models and interventions.” We have a dedicated health economics team that commissions work to assess the economic impact of prevention and early intervention, and an example of this is recent work on bowel cancer in direct response to Taskforce Recommendation 95. This work has summarised the available cost-effectiveness evidence. Cost-effectiveness is a key concept in health economics and is concerned with the value we get from the money spent – where value is often expressed in terms of improving both survival and quality of life. For instance if we invested resources in the best possible way in bowel cancer then we would see improvements in survival, and also improvements in the quality of life of individuals who are staged earlier and therefore do not suffer the more unpleasant effects of treatment that could potentially be avoided. This is why a ‘return on investment’ (RoI) type approach has been followed in this work: how do we make sure that resources are invested in such a way that we achieve health gains at the same time as avoiding health care and other system costs further down the line.

GOOD NEWS - cancer death rates falling; BAD NEWS - cancer incidence rising in persons aged under 50 years, according to the 2024 edition of cancer surveillance statistics published in CA: A Cancer Journal for Clinicians. See: https://lnkd.in/eGm9tzmR William Dahut, Chief Scientific Officer at the American Cancer Society adds, “Cancers driven by OBESITY such as pancreas, kidney, postmenopausal breast cancer, and liver cancers are increasing.” See: https://lnkd.in/gbjGpPZ2 COLORECTAL CANCER is one of at least 13 obesity-related cancers. See the infographic below from the US National Cancer Institute (NCI). 💡 In the late 1990s, it was the FOURTH LEADING CAUSE OF CANCER DEATHS in persons under 50 – both men and women. 💡 In 2024, it is the TOP CAUSE OF CANCER DEATHS IN MEN under 50 and the SECOND LEADING CAUSE FOR WOMEN under 50. 💡 Researchers have found that OBESITY is one of the TOP RISK FACTORS for developing colorectal cancer. 💡 This cancer is 30% more likely to occur in persons with obesity. For insights on the links between obesity and the increasing incidence of some cancers, see: 🔎 US: https://lnkd.in/erhbBse 🔎 China: https://lnkd.in/gkWhBAHw We have much more to learn. Escalating HUMAN HEALTH and ENVIRONMENTAL PRESERVATION CHALLENGES offer OPPORTUNITIES for #innovators, #entrepreneurs, #startups and #smallbusiness to develop SOLUTIONS aimed at PREVENTION, EARLY DETECTION and LOWERING COSTS by addressing ROOT CAUSES. WinSolutions | Win on Impact supports investment in #southeastasia SMEs and startups having viable sustainable innovations relating to #biodiversity, #healthyfood, #nutrition, #health and #healthcare for #EU market entry.